NCT06481943Recruiting
A Prospective Research Investigation of Ischemia Using MCG
SB Technology, Inc.
Start Date
7/11/2024
Completion Date
4/1/2026
Summary
PRISM is a prospective, pilot research study that aims to systematically characterize the usefulness of CardiAQ MCG, a bedside magnetocardiography device, in the evaluation of myocardial ischemia and infarction status.
Eligibility Criteria
Age Range: 18 years to No maximum
Inclusion Criteria:
* Scheduled to undergo a diagnostic angiography or revascularization procedure for the diagnosis or treatment of ischemia or acute myocardial infarction
* Ability for participant to comply with study requirements
* Patient consented before the planned, clinically indicated cath-lab procedure begins to allow sufficient time for study related activities
* Written informed consent
Exclusion Criteria:
* Present STEMI
* Pregnant or breastfeeding
* Having an active atrial fibrillation episode as seen on most current 12-lead ECG
* Active thoracic metal implant
* Poor access to follow-up
Interventions
DEVICE
Sponsor MCG device (CardiAQ)
Conditions
Acute Coronary Syndrome
Locations
Mayo Clinic
Rochester, Minnesota 55905
United States
Mount Sinai Hospital
New York, New York 10029
United States